ArticleNeuropharmacology2018

New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease.

Man Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.